Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients

Clinical trial NCT04616209 · RECRUITING

Trial details

NCT number: NCT04616209
Sponsor: Precision Biotech Taiwan Corp.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2020-11-15
Primary completion: 2027-12-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.